Literature DB >> 10609984

Personality factors moderate subjective and psychophysiological responses to d-amphetamine in humans.

K E Hutchison1, M D Wood, R Swift.   

Abstract

The aim of the present study was to examine the relationship between measures of novelty and sensation seeking and both psychophysiological and subjective measures of stimulation after a pharmacological challenge with an indirect dopamine agonist, d-amphetamine. Prepulse inhibition (PPI) of the startle reflex and subjective responses were assessed after the challenge. The results indicated that the Novelty Seeking scale of the Tridimensional Personality Questionnaire (TPQ; M. Zuckerman, 1994). TPQ was a significant predictor of lower PPI and greater subjective stimulation. The Disinhibition scale of the Sensation Seeking Scale (SSS; M. Zuckerman, S. B. G. Eysenck, & M. J. Eysenck, 1978) moderated the effects of amphetamine on stimulation and elation, whereas the Boredom Susceptibility and Experience Seeking subscales of the SSS moderated subjective stimulation. These findings indicate that higher scores on novelty and sensation seeking correspond to heightened sensitivity to the effects of a stimulant medication.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10609984     DOI: 10.1037//1064-1297.7.4.493

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  36 in total

1.  Individual differences in drug abuse vulnerability: d-amphetamine and sensation-seeking status.

Authors:  Thomas H Kelly; Glenn Robbins; Catherine A Martin; Mark T Fillmore; Scott D Lane; Nancy G Harrington; Craig R Rush
Journal:  Psychopharmacology (Berl)       Date:  2006-09-14       Impact factor: 4.530

2.  Relative expression of D3 dopamine receptor and alternative splice variant D3nf mRNA in high and low responders to novelty.

Authors:  Laurel M Pritchard; Aaron D Logue; Benjamin C Taylor; Rebecca Ahlbrand; Jeffrey A Welge; Yang Tang; Frank R Sharp; Neil M Richtand
Journal:  Brain Res Bull       Date:  2006-07-13       Impact factor: 4.077

Review 3.  Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.

Authors:  Colin N Haile; Thomas R Kosten; Therese A Kosten
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

4.  Experimental evaluation of antitobacco PSAs: effects of message content and format on physiological and behavioral outcomes.

Authors:  Andrew A Strasser; Joseph N Cappella; Christopher Jepson; Martin Fishbein; Kathy Z Tang; Eugene Han; Caryn Lerman
Journal:  Nicotine Tob Res       Date:  2009-02-26       Impact factor: 4.244

5.  Personality and the acute subjective effects of d-amphetamine in humans.

Authors:  Matthew G Kirkpatrick; Chris-Ellyn Johanson; Harriet de Wit
Journal:  J Psychopharmacol       Date:  2013-01-23       Impact factor: 4.153

6.  The reinforcing, subject-rated, performance, and cardiovascular effects of d-amphetamine: influence of sensation-seeking status.

Authors:  William W Stoops; Joshua A Lile; C Glenn Robbins; Catherine A Martin; Craig R Rush; Thomas H Kelly
Journal:  Addict Behav       Date:  2006-10-02       Impact factor: 3.913

7.  Amphetamine effects on startle gating in normal women and female rats.

Authors:  Jo A Talledo; Ashley N Sutherland Owens; Tijmen Schortinghuis; Neal R Swerdlow
Journal:  Psychopharmacology (Berl)       Date:  2009-01-16       Impact factor: 4.530

8.  The amphetamine response moderates the relationship between negative emotionality and alcohol use.

Authors:  Kenneth J D Allen; Frances H Gabbay
Journal:  Alcohol Clin Exp Res       Date:  2012-12-14       Impact factor: 3.455

9.  Comorbidity of psychiatric disorders and nicotine dependence among adolescents: findings from a prospective, longitudinal study.

Authors:  Pamela C Griesler; Mei-Chen Hu; Christine Schaffran; Denise B Kandel
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-11       Impact factor: 8.829

10.  Pramipexole effects on startle gating in rats and normal men.

Authors:  Neal R Swerdlow; Sophia A Lelham; Ashley N Sutherland Owens; Wei-Li Chang; Sebastiaan D T Sassen; Jo A Talledo
Journal:  Psychopharmacology (Berl)       Date:  2009-06-09       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.